Hydroxyurea for the treatment of sickle cell disease.

Hydroxyurea in sickle cell disease: drug review.

Emerging science of hydroxyurea therapy for pediatric sickle cell disease.

Treatment of sickle cell anemia with hydroxyurea and erythropoietin.

Does hydroxyurea prevent pulmonary complications of sickle cell disease?

Hydroxyurea in Sickle Cell Disease: Our Experience in Western India.

Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease.

Hydroxyurea and growth in young children with sickle cell disease.

Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.

Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.

Reduced plasma angiotensin II levels are reversed by hydroxyurea treatment in mice with sickle cell disease.

A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.

Shared decision making for hydroxyurea treatment initiation in children with sickle cell anemia.

Morphine for the treatment of pain in sickle cell disease.

Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision.

The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients.

Update on the use of hydroxyurea therapy in sickle cell disease.

Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent.

Immunologic effects of hydroxyurea in sickle cell anemia.

Influence of βS-Globin Haplotypes and Hydroxyurea on Arginase I Levels in Sickle Cell Disease.

Survival and mortality among users and non-users of hydroxyurea with sickle cell disease.

Higher nocturnal and awake oxygen saturations in children with sickle cell disease receiving hydroxyurea therapy.

Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.

Genome editing and stem cell therapy pave the path for new treatment of sickle-cell disease.

Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.

Suggest Documents

Hydroxyurea in sickle cell disease: drug review.

Emerging science of hydroxyurea therapy for pediatric sickle cell disease.

Treatment of sickle cell anemia with hydroxyurea and erythropoietin.

Does hydroxyurea prevent pulmonary complications of sickle cell disease?

Hydroxyurea in Sickle Cell Disease: Our Experience in Western India.

Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease.

Hydroxyurea and growth in young children with sickle cell disease.

Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.

Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.

Reduced plasma angiotensin II levels are reversed by hydroxyurea treatment in mice with sickle cell disease.

A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.

Shared decision making for hydroxyurea treatment initiation in children with sickle cell anemia.

Morphine for the treatment of pain in sickle cell disease.

Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision.

The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients.

Update on the use of hydroxyurea therapy in sickle cell disease.

Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent.

Immunologic effects of hydroxyurea in sickle cell anemia.

Influence of βS-Globin Haplotypes and Hydroxyurea on Arginase I Levels in Sickle Cell Disease.

Survival and mortality among users and non-users of hydroxyurea with sickle cell disease.

Higher nocturnal and awake oxygen saturations in children with sickle cell disease receiving hydroxyurea therapy.

Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.

Genome editing and stem cell therapy pave the path for new treatment of sickle-cell disease.

Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.

Hydroxyurea for the treatment of sickle cell disease.

Recommend Documents

Follow Us